BTIG lowered the firm’s price target on Intuitive Surgical (ISRG) to $542 from $560 and keeps a Buy rating on the shares following. Intuitive Surgical’s Q1 procedure growth exceeded the Street by 240 basis points as Systems fell short by 40 units, the analyst tells investors in a research note. Procedure demand is healthy, Intuitive Surgical is taking up procedure guidance as a sign of confidence, and is seeing steady utilization increases across all key platforms, the firm argues.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical price target lowered to $590 from $605 at Truist
- Intuitive Surgical price target lowered to $575 from $670 at Piper Sandler
- Intuitive Surgical price target lowered to $575 from $600 at Baird
- Intuitive Surgical: Strong Performance and Growth Potential Amidst Challenges
- Intuitive Surgical Reports Strong Q1 2025 Earnings